Default: International Journal of Neuropsychopharmacology

ISSN: 1461-1457

Journal Home

Journal Guideline

International Journal of Neuropsychopharmacology Q1 Unclaimed

Oxford University Press United Kingdom
Unfortunately this journal has not been claimed yet. For this reason, some information may be unavailable.

International Journal of Neuropsychopharmacology is a journal indexed in SJR in Pharmacology and Psychiatry and Mental Health with an H index of 125. It is an CC BY-NC Journal with a Single blind Peer Review review system, and It has a price of 1540 €. The scope of the journal is focused on neuropsychopharmacology, neuroimaging, neuropsychology, psychiatry, pharmacology, psychoneuroendocrinology. It has an SJR impact factor of 1,525 and it has a best quartile of Q1. It is published in English. It has an SJR impact factor of 1,525.

International Journal of Neuropsychopharmacology focuses its scope in these topics and keywords: cocaine, depression, patients, kinases, serotonin, gsrdneocortical, european, effect, earlyonset, doubleblind, ...

Type: Journal

Type of Copyright: CC BY-NC

Languages: English

Open Access Policy: Open Access

Type of publications:

Publication frecuency: -

Price

1540 €

Inmediate OA

NPD

Embargoed OA

- €

Non OA

Metrics

International Journal of Neuropsychopharmacology

1,525

SJR Impact factor

125

H Index

79

Total Docs (Last Year)

261

Total Docs (3 years)

4188

Total Refs

1265

Total Cites (3 years)

254

Citable Docs (3 years)

4.59

Cites/Doc (2 years)

53.01

Ref/Doc

Comments

No comments ... Be the first to comment!

Aims and Scope


cocaine, depression, patients, kinases, serotonin, gsrdneocortical, european, effect, earlyonset, doubleblind, dorsal, findingsactivation, firstepisode, food, g, gain, gateway, gene, glutamate, disorders, disorderantipsychotic, binding, cadependent, cognitive, compulsive, conditioninghypothalamic, contextual, cortex, coupled, cues, darpp, deficits, degree, dependenceprotein, disorder, neuropsychopharmacology, neuroimaging, neuropsychology, psychiatry, pharmacology, psychoneuroendocrinology



Best articles by citations

Influence of immobilization stress on the levels of CaMKII and phospho-CaMKII in the rat hippocampus

View more

Fluvoxamine CR in the long-term treatment of social anxiety disorder: the 12- to 24-week extension phase of a multicentre, randomized, placebo-controlled trial

View more

Serotonergic Psychedelics Temporarily Modify Information Transfer in Humans

View more

Tolerance to the anhedonic effects of lipopolysaccharide is associated with changes in syntaxin immunoreactivity in the nucleus accumbens

View more

Acute augmentation of serotonin suppresses cardiovascular responses to emotional valence

View more

Do antidepressants help much in comparison to placebo?

View more

Focus on CaMKII: a molecular switch in the pathophysiology and treatment of mood and anxiety disorders

View more

Pathways to schizophrenia: the impact of environmental factors

View more

Methylation at a transcription factor-binding site on the 5-HT1A receptor gene correlates with negative symptom treatment response in first episode schizophrenia

View more

Pioneers in Psychopharmacology II

View more

Differential effect of lithium on spermidine/spermine N1-acetyltransferase expression in suicidal behaviour

View more

QT interval variability in panic disorder patients after isoproterenol infusions

View more
SHOW MORE ARTICLES

Repetitive transcranial magnetic stimulation (rTMS) in the double-blind treatment of a depressed patient suffering from bulimia nervosa: a case report

View more

Safety and efficacy of combined clozapine-lithium pharmacotherapy

View more

The effects of olanzapine on neurocognitive functioning in medication-refractory schizophrenia

View more

The effect of chronic treatment with clozapine and haloperidol on stimulus control by DOM

View more

Repetitive transcranial magnetic stimulation to right prefrontal cortex does not modulate the psychostimulant effects of amphetamine

View more

How to treat bipolar II depression and bipolar II mixed depression?

View more

How to treat bipolar II depression and bipolar II mixed depression? -A reply to Benazzi

View more

Serotonin Signaling Trough Prelimbic 5-HT1A Receptors Modulates CSDS-Induced Behavioral Changes in Adult Female Voles

View more

Serotonin syndrome -'potential' role of the CYP2D6 genetic polymorphism in Asians

View more

The cholinergic deficit in Alzheimer's disease: impact on cognition, behaviour and function

View more

Prolactin response to d-fenfluramine in combat-related post-traumatic stress disorder

View more

Algorithm-based treatment of major depression in an outpatient clinic: clinical correlates of response to a specific serotonin reuptake inhibitor and to triiodothyronine augmentation

View more

FAQS